Fluxion’s ERASE-Seq is panel and sequencer agnostic. ERASE-Seq can be easily adapted to any panel and sequencer through a straightforward statistical modeling process based on the user’s existing sequencing data. Once validation is completed, ERASE-Seq can be used via cloud-based or local software instances to analyze sequencing data. This allows labs with existing, validated panels for solid tissue to map the identical panel over to liquid biopsy use without any chemistry changes- no barcodes required! Fluxion can also develop custom amplicon panels based on the user’s requirements, including panels up to 500 genes. Turnaround time for panel development is normally one week. Examples of recent projects include development of 50-gene melanoma panel for The Cleveland Clinic, and design of a custom panel for hepatocellular carcinoma.
Custom panel development is available immediately, read more!